A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

PD-1 inhibitors belong to a class of medications known as immune checkpoint inhibitors, which have become an important part of many modern cancer treatment plans. PD-1 inhibitors work by helping the ...

Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...

When a drug is injected directly into a tumour, macrophages already present in the body absorb the drug and begin producing ...

A New Jersey woman has been given a second chance at life, thanks to a new cancer therapy. Pamela Goldberger, 65, found out in 2023 that she had glioblastoma — a devastating diagnosis with an average ...

Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

The researchers describe how an injection directly into the tumor can deliver small lipid-based particles to these cells. The ...

Cellares and City of Hope are partnering to evaluate automating CAR T manufacturing for glioblastoma brain cancer therapy.

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...